• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (COVINGTON) -1018233 LATEX FOLEY CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (COVINGTON) -1018233 LATEX FOLEY CATHETER Back to Search Results
Device Problem Biocompatibility (2886)
Patient Problems Urinary Frequency (2275); Hematuria (2558); Dysuria (2684)
Event Date 06/16/2021
Event Type  Injury  
Manufacturer Narrative
The investigation is still in progress.Once the investigation is complete a supplemental report will be filed.
 
Event Description
It was reported that the patient underwent general anesthesia right transurethral ureteral stenting and right ureteroscopy on (b)(6) 2021.The patient underwent the removal of urinary catheter on the next day after surgery.The patient experienced urinary hematuria appeared when urinating, accompanied by urinary frequency, urgency, and painful urination.The treatment included piperacillin sodium tazobactam anti-infection, kidney protection, stomach protection, rehydration, and other symptomatic supportive treatment.After treatment was provided, the condition improved and hematuria, urinary frequency, urgency, urinary pain disappeared.
 
Event Description
It was reported that the patient underwent general anesthesia right transurethral ureteral stenting and right ureteroscopy on (b)(6) 2021.The patient underwent the removal of urinary catheter on the next day after surgery.The patient experienced urinary hematuria appeared when urinating, accompanied by urinary frequency, urgency, and painful urination.The treatment included piperacillin sodium tazobactam anti-infection, kidney protection, stomach protection, rehydration, and other symptomatic supportive treatment.After treatment was provided, the condition improved and hematuria, urinary frequency, urgency, urinary pain disappeared.
 
Manufacturer Narrative
Per additional information received, the customer confirmed the urinary catheter that the patient used did not belong to bard/bd device.Hence, bd has determined that this mdr event is not reportable.H11: section a through f - the information provided by bard represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bard.H3 other text : the device was not returned.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LATEX FOLEY CATHETER
Type of Device
LATEX FOLEY CATHETER
Manufacturer (Section D)
C.R. BARD, INC. (COVINGTON) -1018233
8195 industrial blvd
covington 30014
Manufacturer (Section G)
C.R. BARD, INC. (COVINGTON) -1018233
8195 industrial blvd
covington 30014
Manufacturer Contact
yonic anderson
8195 industrial blvd
covington 30014
7707846100
MDR Report Key13152700
MDR Text Key283160122
Report Number1018233-2022-00001
Device Sequence Number1
Product Code EZC
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
K910846
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 01/25/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/04/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/21/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age67 YR
Patient SexMale
-
-